Polyamine Metabolism and the DHPS/eIF5A Hypusination Axis: From Metabolic Reprogramming to a Therapeutic Achilles’ Heel in Melanoma
Biomolecules · 13.04.2026 · 16 (4) · 574
DOI: 10.3390/biom16040574 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 13.04.2026. Verfasst von Kai-Li Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Engineering, Jining Medical University, Jining 272067, China. Hauptthemen laut MEDLINE: Peptide Initiation Factors, Melanoma, Polyamines, RNA-Binding Proteins. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shandong Provincial Natural Science Foundation Youth Fund, Jining Medical University Innovation and Entrepreneurship Training Program for College Stu-dentsJining Medical University Innovation and Entrepreneurship Train…, the Startup Grant for Research of Jining Medical University.
Abstract (Originalsprache)
The polyamine metabolic pathway, an evolutionarily conserved nexus integrating nutrient sensing, translation control, and cellular proliferation, is fundamentally rewired in cancer. Melanoma, a malignancy of melanocytes notorious for its metastatic propensity and therapy resistance, exhibits a profound dependency on this pathway, extending beyond mere polyamine abundance to the specialized function of their derivative, hypusine. This review synthesizes cutting-edge insights into the deoxyhypusine synthase (DHPS)/eukaryotic initiation factor 5A (eIF5A) hypusination circuit as a critical amplifier of oncogenic signaling in melanoma. We dissect its role as a translational rheostat for pro-tumorigenic proteomes, a driver of phenotypic plasticity underpinning invasion and vasculogenic mimicry, and a modulator of the immunosuppressive tumor microenvironment. Moving beyond the classical inhibitor GC7, we explore the emergence of novel allosteric DHPS inhibitors with compelling preclinical efficacy. Finally, we propose a paradigm shift: targeting the DHPS/eIF5A axis represents a strategy to disrupt the “non-oncogene addiction” of melanoma—its reliance on hyperactive translation and adaptive survival mechanisms—offering a promising avenue alongside targeted therapies and immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medical Engineering, Jining Medical University, Jining 272067, China.
Förderung
- the Shandong Provincial Natural Science Foundation Youth Fund
- Jining Medical University Innovation and Entrepreneurship Training Program for College Stu-dentsJining Medical University Innovation and Entrepreneurship Train…
- the Startup Grant for Research of Jining Medical University
- Shandong Colleges Youth Innovation & Tech Support Program
- Shandong Provincial Natural Science Foundation Youth Fund
- Jining Medical University Innovation and Entrepreneurship Training Program for College Students
- Startup Grant for Research of Jining Medical University
Zitieren
APA
Liu, K. L., Zhang, S., Li, F. S., Chen, M. J., Chen, Y. Y., Zhang, N., & Wang, K. (2026). Polyamine Metabolism and the DHPS/eIF5A Hypusination Axis: From Metabolic Reprogramming to a Therapeutic Achilles’ Heel in Melanoma. Biomolecules, 16(4), 574. https://doi.org/10.3390/biom16040574
Vancouver
Liu KL, Zhang S, Li FS, Chen MJ, Chen YY, Zhang N, et al. Polyamine Metabolism and the DHPS/eIF5A Hypusination Axis: From Metabolic Reprogramming to a Therapeutic Achilles’ Heel in Melanoma. Biomolecules. 2026;16(4):574. doi:10.3390/biom16040574
BibTeX
@article{Liu2026,
author = {Liu, Kai-Li and Zhang, Shuo and Li, Feng-Shuo and Chen, Min-Jin and Chen, Yuan-Yuan and Zhang, Ning and Wang, Kai},
title = {Polyamine Metabolism and the DHPS/eIF5A Hypusination Axis: From Metabolic Reprogramming to a Therapeutic Achilles’ Heel in Melanoma},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {4},
pages = {574},
doi = {10.3390/biom16040574}
}
EUVIMED